144 related articles for article (PubMed ID: 9815695)
1. A phase I trial of a new recombinant human beta-interferon (BG9015) for the treatment of patients with recurrent gliomas.
Fine HA; Wen PY; Robertson M; O'Neill A; Kowal J; Loeffler JS; Black PM
Clin Cancer Res; 1997 Mar; 3(3):381-7. PubMed ID: 9815695
[TBL] [Abstract][Full Text] [Related]
2. Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a childrens cancer group phase I/II study.
Packer RJ; Prados M; Phillips P; Nicholson HS; Boyett JM; Goldwein J; Rorke LB; Needle MN; Sutton L; Zimmerman RA; Fitz CR; Vezina LG; Etcubanas E; Wallenberg JC; Reaman G; Wara W
Cancer; 1996 May; 77(10):2150-6. PubMed ID: 8640684
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.
Fine HA; Wen PY; Maher EA; Viscosi E; Batchelor T; Lakhani N; Figg WD; Purow BW; Borkowf CB
J Clin Oncol; 2003 Jun; 21(12):2299-304. PubMed ID: 12805330
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic guided laser-induced interstitial thermotherapy (SLITT) in gliomas with intraoperative morphologic monitoring in an open MR: clinical expierence.
Leonardi MA; Lumenta CB
Minim Invasive Neurosurg; 2002 Dec; 45(4):201-7. PubMed ID: 12494354
[TBL] [Abstract][Full Text] [Related]
5. [Treatment modalities for malignant gliomas with reference to their pathophysiology].
Kobayashi S; Takakura K
Gan To Kagaku Ryoho; 1986 Jan; 13(1):11-7. PubMed ID: 3942392
[TBL] [Abstract][Full Text] [Related]
6. Autologous natural killer cell therapy for human recurrent malignant glioma.
Ishikawa E; Tsuboi K; Saijo K; Harada H; Takano S; Nose T; Ohno T
Anticancer Res; 2004; 24(3b):1861-71. PubMed ID: 15274367
[TBL] [Abstract][Full Text] [Related]
7. [A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas].
Mizumatsu S; Matsumoto K; Maeda Y; Tamiya T; Furuta T; Ohmoto T
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2055-60. PubMed ID: 9838907
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy in supratentorial gliomas. A study of 821 cases.
Heesters M; Molenaar W; Go GK
Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
[TBL] [Abstract][Full Text] [Related]
10. [Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma].
Linassier C; Destrieux C; Benboubker L; Alcaraz L; Bergemer-Fouquet AM; Jan M; Calais G; Colombat P
Bull Cancer; 2001 Sep; 88(9):871-6. PubMed ID: 11604360
[TBL] [Abstract][Full Text] [Related]
11. High-grade astrocytomas.
Wen PY; Fine HA; Black PM; Shrieve DC; Alexander E; Loeffler JS
Neurol Clin; 1995 Nov; 13(4):875-900. PubMed ID: 8584002
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
Watanabe K; Kanaya H; Fujiyama Y; Kim P
Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
[TBL] [Abstract][Full Text] [Related]
13. Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.
Söling A; Sackewitz M; Volkmar M; Schaarschmidt D; Jacob R; Holzhausen HJ; Rainov NG
Clin Cancer Res; 2005 Jan; 11(1):249-58. PubMed ID: 15671553
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of pediatric gliomas: implications for the development of future therapies.
Pytel P
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S51-60. PubMed ID: 18076319
[TBL] [Abstract][Full Text] [Related]
16. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
[TBL] [Abstract][Full Text] [Related]
17. Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid.
Yung WK; Kyritsis AP; Gleason MJ; Levin VA
Clin Cancer Res; 1996 Dec; 2(12):1931-5. PubMed ID: 9816151
[TBL] [Abstract][Full Text] [Related]
18. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
19. [Primary brain tumors].
Cohen J; Cohen Y; Kuten A
Harefuah; 1996 Nov; 131(10):387-90, 456. PubMed ID: 8981815
[TBL] [Abstract][Full Text] [Related]
20. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
